Richter transformation recommendations
In this issue of Blood, an international group of experts coordinated by the European Research Initiative on CLL (ERIC) reports consensus recommendations o
Related Articles
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Key Points. Sustained minimal residual disease negativity below 10-5 is the best predictor of outcomes in newly diagnosed multiple myeloma.Similar results
BPDCN: state of the art
Abstract. The emergence of blastic plasmacytoid dendritic cell neoplasm (BPDCN) as its own distinct entity within the pantheon of hematologic malignancies
How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission
Great strides forward have been taken in the last decade in the management of acute lymphoblastic leukemia in adults via the application of genomics, monit
Atypical cytoplasmic inclusions and erythrophagocytosis in acute myeloid leukemia with KMT2A::MLLT3 and U2AF1 mutation
Shuying Chen, Zhijian Xiao; Atypical cytoplasmic inclusions and erythrophagocytosis in acute myeloid leukemia with KMT2A:: MLLT3 and U2AF1 mutation. Blood 2025; 146 (6): 765. doi:…
Volume 146 Issue 6 | Blood | American Society of Hematology
Designing randomized clinical trials (RCTs) that are fit for purpose to answer burning questions in routine practice is difficult, and the interpretation of their results,…
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis
Key Points. POD post-CAR-T for R/R MCL is associated with short OS and time from CAR-T infusion to POD, predicted inferior OS in this settingBispecific…
Is Combination Therapy Warranted in Myelofibrosis? | ASH Clinical News | American Society of Hematology
Leah Lawrence is a freelance health writer and editor based in Delaware. Naveen Pemmaraju, MD Gabriela Hobbs, MD When the JAK inhibitor ruxolitinib received its…
Red blood cell aggregation within a blood clot causes platelet-independent clot shrinkage
Key PointsRBCs suspended in platelet-depleted plasma undergo aggregation within a thrombin-induced clot and cause platelet-independent clot shrinkage.RBC-i
HLH: it is all about communication
In this issue of Blood, Frank-Kamenetskii and colleagues, using a refinement of an in vitro murine cellular model of hemophagocytic lymphohistiocytosis (HL
HLH: it is all about communication
In this issue of Blood, Frank-Kamenetskii and colleagues, using a refinement of an in vitro murine cellular model of hemophagocytic lymphohistiocytosis (HL